{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"42.180","rs_stock_flag":false,"fiscal_year_end":"2025年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"420,285,370","primaryexch":"香港交易所","ric":"2591.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BVN1Y26","am":"19.18","iv":"","ew_strike":"","as":"41.840","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"41.500","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"40.080","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Wang Qinghua","underlying_ric":"2591.HK","hi52":"74.000","issuer_name":"廣州銀諾醫藥集團股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"41.000","mkt_cap":"17.58","f_aum_hkd":null,"ew_sub_per_to":"","ls":"41.840","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"+0.060","aum":"","issued_shares_class_B":null,"vo":"458.00","secondary_listing_flag":false,"listing_date":"2025年8月15日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"廣州銀諾醫藥集團股份有限公司 - B - H股","nm_s":"銀諾醫藥－Ｂ","sym":"2591","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"廣州銀諾醫藥集團股份有限公司是一家主要從事醫藥產品的研發及商業化的中國投資控股公司。該公司主要從事商業化原研人源長效胰高血糖素樣肽-1（GLP-1）受體激動劑。該公司致力於開發糖尿病和其他代謝性疾病的療法。該公司的主要產品依蘇帕格魯肽α（商品名：怡諾輕）用於治療2型糖尿病（T2D）。該公司的主要候選藥物管線產品包括YN014、YN401、YN209、YN203和YN202。該公司主要在國內市場經營其業務。","op":"41.820","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國廣州市黃埔區<br/>騰飛二街2號<br/>自編號創意樓<br/>H座409室","pc":"+0.14","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"41.780","isin":"CNE1000071Q7","moneyness":""}},"qid":"1759074326762"}
